| 1. |
TEASING
StemVet Science Repair provides winning edge for the first group race of the Australian Thoroughbred racing season with 7 year old miracle mare Teasing. |
| 2. |
Pain Free Racing
Medivet launches drug free all natural pain relief product Bio Bute.
Bio Bute is a simple to use rub in solution for all performance and competitive animals that does not swab.
|
| 3. |
Medivet secures full manufacturing and intellectual property rights for the world premium StemVet Science range of products |
| 4. |
Breeders embrace Stem Cell treatment.
Leading studs are trialling Medivet’s StemVet Science Biological Breeding on their royally bred broodmares and stallions. |
5. |
Record continues in the USA.
Princes Regal, the daughter of New Zealand’s most expensive Standard Bred yearling ever sold at auction, registers its fourteenth win on StemVet Activation by an impressive five length margin.
|
| 6. |
Dubai and Kentucky embrace Australian Stem Cell Technology.
Recent visit to Dubai and Kentucky produce keen interest by world class breeders for Medivet’s StemVet Science state of the art stem cell technologies. |
| 7. |
Scientific Stem Cell Breakthrough.
Medivet has developed advanced stem cell harvesting procedures using adipose derived stem cell kits making it available to all veterinarians at a fraction of the cost of alternative techniques. This will provide veterinarian practitioners the ability to perform stem cell procedures in house for the first time at an affordable cost to their clients. |
| 8. |
World’s first intravenous adipose stem cell treatment for Group winning thoroughbred.
Medivet’s Research Division has recently performed cutting edge adipose stem cell treatment on a mares severe tendon tear with outstanding results. |
| 9. |
Old Stallion defies the odds.
27 year old stallion continues remarkable fertility success using StemVet Biological Breeding in the off season for a second consecutive season has maintained a 60% to 90% successful fertility increase in the barn. |
| 10. |
Cells Tracked
Recent trials using scintigraphy nuclear medicine have been undertaken by Medivet to tag and track stem cells through the animal after using intravenous treatment of adipose stem cell therapy. |
| 11. |
Medivet America
Medivet secures its joint venture partner in the USA.
Medivet P/L and Delc Inc of Lexington, Kentucky have formed a joint venture company Medivet America LLC. The partners are excited about the possibility of rolling out Medivet’s stem cell technologies in the world’s largest market. |
| 12. |
Medivet P/L appoints David Petrowski as CEO of Medivet America LLC.
David Petrowski will be attending the Western Veterinary Conference in Las Vegas in February 2010. Medivet will exhibit and launch to 6,000 veterinarians attending, the Medivet adipose stem cell procedure and other Medivet stem cell technologies. Following the conference David will be heading to Kentucky to formally sign the joint venture relationship and launch the Medivet products and technologies to the USA market.
|
| 13. |
Gigantic Leap in Stem Cell Count.
Medivet’s adipose derived stem cell procedure in latest trial.
Tests have confirmed staggering stem cell count present in the cells harvested from the adipose tissues utilising Medivet’s Adipose Stem Cell Procedure Kit, recording up to 2 million stem cells per gram. These results achieved by Medivet will revolutionise the benefits of regenerative medicine available through all veterinarians.
|
| 14. |
Bio Bute Pain Relief Breaks new Ground.
Medivet has submitted to the APVMA for registration, Bio Bute, its all natural pain relief product. Once registered Bio Bute will be the only all natural pain relief product that really delivers. |
| 15. |
StemVet Equine trials to be undertaken in Kentucky. |
| 16. |
Medivet Cracks Peptide
A new synthetic customized peptide, TB500, is now available to the veterinary profession for trials for the prevention of type 1 diabetes in dogs.
Medivet also welcomes veterinarians to participate in further trials in the equine arena as early trials indicate substantial benefits to the performance of individual horses.
|
| 17. |
Medivet’s TB500 shows Bleeders the Way.
Early trials indicate amazing results with thymosin beta 4 peptide, TB500 for addressing equine pulmonary haemorrhage,( bleeders).
Medivet welcomes all veterinarians to participate in further trials for equine bleeders.
|
| 18. |
Medivet launches Clear Scope, Equine Oral Decongestant and Expectorant.
Clear Scope, designed to eliminate mucus and congestion in the lungs and the respiratory tract, is a must in every equine stable.
|
| 19. |
Medivet launches Stem Cell Technology at Inglis Bloodstock, Newmarket.
September 2009 saw the launch of Medivet’s Stem Cell Technology to Sydney based Veterinarians at Newmarket and Hunter Valley veterinarians at Scone. The well attended Information Seminars introduced StemVet Science products, Stem cell laser technology and Medivet’s Adipose tissue extraction
|